This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hot Topics in Hyperthermia

Hot Topics in Hyperthermia

Format

Slide Lecture Series

Time to Complete

1.50 hours

Released

March 1, 2018

Expires

March 1, 2019
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 CreditsTM

Pharmacy Credits

Pharmacists may earn 1.50 CPE Credits (0.15 CEUs) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website, and free registration on the ASHP website is required). Your certificate will save on ASHP.org and will not be included in your myCME CME History. Be prepared to provide your NABP eProfile ID, birth month and date (required for ASHP to submit your credits to CPE Monitor).

Accredited Provider



This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).

Commercial Supporter

Supported by an educational grant from Eagle Pharmaceuticals, Inc.

Program Description

Hyperthermic conditions, such as malignant hyperthermia and exertional heat stroke, are medical emergencies that necessitate immediate recognition and treatment. Healthcare professionals need to know which factors predispose people to developing a hyperthermic emergency. If not treated immediately, patients may suffer neurologic sequelae, cognitive effects, multi-system organ failure, and death. This educational activity will review current strategies for preventing, recognizing, and treating hyperthermic conditions. Patient cases will be used to illustrate best practices in the management of hyperthermic conditions.

Intended Audience

This activity was planned to meet the educational needs of physicians, pharmacists, physician assistants, and nurse practitioners potentially involved in the management of patients with life-threatening hyperthermic conditions.

Educational Objectives

At the conclusion of this application-based educational activity, participants should be able to:

  • Review factors that predispose people to developing hyperthermic conditions
  • Explain the morbidity and mortality of hyperthermia
  • Review current strategies for preventing, recognizing, and treating hyperthermic conditions
  • Using patient cases, illustrate best practices in the management of hyperthermic conditions

Conflict Of Interest Disclosure Policy

In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships. No persons associated with this activity have disclosed any relevant financial relationships.

Faculty

Daniel P. Hays, PharmD, BCPS, FASHP, Activity Chair
Clinical Pharmacy Specialist
Departments of Pharmacy and Emergency Medicine
University Medical Center
Las Vegas, NV

Dr. Hayes has no relevant financial relationships to disclose.

Frank LoVecchio, DO, MPH, ABMT, FACEP
Vice-Chair and Research Director, Maricopa Medical Center
Professor of Emergency Medicine, Pharmacology, and Medicine
University of Arizona College of Medicine
Co-Medical Director, Banner Poison and Drug Information Center
Phoenix, AZ

Dr. LoVecchio has no relevant financial relationships to disclose.

Accredited Provider Disclosure

The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Instructions

In order to receive credit, participants must view the activity and complete the post-test and program evaluation. Participants must score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact elearning@ashp.org.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue